Capital Ventures discloses passive stakes in two biotech names

|By:, SA News Editor

Capital Ventures reports a 7.1% passive stake in Aeterna Zentaris (AEZS +1.8%) and a 7% passive stake in Northwest Biotherapeutics (NWBO +1.9%).

13Gs here and here.